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ABSTRACT  
Cleome gynandra is a medicinal plant that is used all over Uganda to hasten childbirth because, it 
possesses the ability to contract the uterus. It is also used as an abortifacient in the first trimester. 
In this study, the effects of Cleome gynandra were investigated on the estrous cycle and the 
histology of the ovary and uterus of adult Wistar rat. Twelve adult female Wistar rats of 130-140g 
average weight were used. These were divided into three groups of four animals each. Group A 
received distilled water only, while animals in groups B and C received 250mg/kg body weight and 
500mg/kg body weight of extract, orally and daily respectively. Monitoring of estrous cycle continued 
throughout the three weeks of extract administration. After three weeks, the ovaries and uteri were 
excised and processed for histological examination. In the ovary, there was a reduction in number 
of primordia, primary, secondary and graafian follicles in the treated groups. Vacuolations were 
common to both the ovarian and uterine tissues of treated animals. The estrous cycle of Group B 
and C, showed a mild disruption when compared to animals in Group A. The results showed that the 
plant extract studied, exerted negative influences on the estrous cycle and histology of the ovary and 
uterus of Wistar albino rats, suggesting a disturbance on the reproductive health of the animals. 
Further studies to determine the mechanism of action of Cleome gynandra on the ovary and uterus 
and the levels of FSH, LH, estradiol and progesterone is recommended.  
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INTRODUCTION  
The use of plants for medicinal and 
mythological purposes, and for solving 
problems related to ill health has been 
practiced in the African and other societies for 
many years (Mohammed et al., 2014). Some 
of the factors that help to increase the use of 
herbal medicines include its availability, 
cultural significance, history of known 
effectiveness, and most significantly, easy 
access compared to the modern 
pharmaceuticals (Thomford et al., 2015). 
Approximately, 40– 50% of all marketed 
drugs are either obtained from herbs or their 
use is stirred by medicinal plants (Ekor, 2014). 
The World Health Organization approximates 
that 80% of the population in Africa depend 
on traditional medicines for their primary 
health care needs (WHO, 2005), this figure 
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increases to about 90% of the population in 
developing countries (Robinson and Zhang, 
2011).  
The female reproductive system is extremely 
sensitive to several factors such as the life 
style, radiation, drugs and toxicants (Fucic et  
al., 2012). Exposure to any of these and 
other factors could lead to congenital 
abnormalities in infants and even functional 
alterations in adults (Knapp et al., 2012). Any 
interference that alters the normal 
functioning of the organs of reproduction 
affects the ability of the animal to reproduce.   
Cleome gynandra (C. gynandra), is a 
medicinal plant that belongs to the botanical 
family Capparaceae. Phytochemical screening 
of a methanolic extract of C. gynandra 
showed that the plant contains saponins, 
phenols, flavonoids, steroids and proteins, 
hence making it beneficial in the treatment of 
various diseases (Kalita, 2014).  It is widely 
distributed across the world and is found all 
over the greater part of Africa (Mishra et  
al., 2011). It is seen mostly in waste land and 
is propagated by seeds that are widely 
dispersed, germinating during rainy season 
(Ekpong, 2009). C. gynandra is popularly 
known as Cat’s whiskers in English and in 
Uganda, it is known as Ejjobyo in Luganda 
meaning ‘bitter plant’ (Moshi et al., 2012). 
Studies have shown that, several plants and 
plant products affect the female reproductive 
system in a number of ways. Previous studies 
have shown that, C. gynandra has capacity 
to contract the uterus in rats (Kamatenesi-
Mugisha and Oryem-Origa, 2007). In their 
study, the oxytocic effect of C. gynandra on 
the uterus was tested in vitro. This, 
compliments the report of Singh et al. (2006), 
who listed C. gynandra as one of the several 
herbal medicines used to terminate 
pregnancy in Uganda. Despite the many uses 
of C. gynandra, its effects on the estrous 
cycle and on the histological organisation of 
the organs of the reproductive systems is not 
known. Hence, there is still need to explore 
and verify its nature in science and everyday 
traditional healthcare. Indeed, this research 
aims at finding some scientific basis of the 
effects of C. gynandra, on the estrous cycles, 
ovaries and uterus in Wistar albino rats.  
 
MATERIALS AND METHODS 
 
This was an experimental study to evaluate 
the effects of C. gynandra aqueous leaf 
extract on the estrous cycle and the histology 
of the ovary and the uterus of laboratory 
Wistar albino rats (Rattus Norvegicus). 
Twelve (12) adult female Wistar rats, ten (10) 
weeks old, weighing between 130-140g, 
were purchased from the animal facility, of 
the Pharmacology Department, Kampala 
International University, Western campus. 
The animals were allowed to acclimatize for a 
period of two weeks before commencement 
of the experiment. The animals were kept in 
appropriate cages with wired open tops at 
constant temperature of 21+2°C, with an 
alternate 12-hour light and dark cycle. Saw 
dust was used as beddings for the cages. The 
animals were given standard rat pellet diet 
obtained from Mice Meal LTD, Jinja, Uganda. 
They were also provided with distilled water.   
Animals were randomly assigned into three 
groups; A, B and C of four (4) animals per 
group with approximately equal mean body 
weight. Group A served as control and 
received 1ml of distilled water, while group B 
and C received extract at 250mg/kg B.W and 
500mg/kg B.W, orally and daily respectively.  
The extract was prepared using the method 
described by Namulindwa et al. (2015), with 
slight modification. Briefly, fresh plant 
materials were harvested in November 2016, 
from gardens and open fields around the 
Kampala International University, Bushenyi 
District, in Western Uganda. The specimens 
were taken to a qualified Taxonomist for 
authentication at the Department of Botany, 
Faculty of Science, Mbarara University of 
Science and Technology, Uganda. It was 
identified as Cleome gynandra and issued 
with a collector number #001, a sample of this 
was kept for future references.  
The plants were washed thoroughly in running 
tap water and shade dried at room 




temperature for 14 days. Dried leaves were 
grinded into a fine powder using an electric 
blender and stored in air tight bottles until 
use. One hundred grams (100g) of the 
powder, was macerated in 1 litre of distilled 
water and left on a mechanical shaker for 24 
hours to permit complete extraction. The 
solution obtained was filtered repeatedly 
using a vacuum pump filter with Whatman 
filter paper No. 1, to obtain the filtrate. 
Thereafter, the mixture was concentrated by 
evaporating using a water bath at 60°C to a 
semi solid form of constant weight. The 
resulting extract was stored at 4°C in a 
refrigerator till further use.   
The use of the aqueous extract for this study 
is designed to mimic human consumption of 
C. gynandra traditionally.  
Vaginal smears of each rat were taken at 
approximately the same time between 7am 
and 9am every morning for five weeks (2 
weeks before treatment and 3 weeks during 
treatment), to ensure regular estrous cycles. 
The materials used were 1ml rubber pipette, 
beakers, distilled water, glass slide and a light 
microscope. The animals were held in a 
supine position in one hand and with the 
other hand, using the rubber pipette, 0.5ml 
of distilled water was flushed into the vagina 
orifice twice. The vagina fluid was collected 
and carefully placed on the glass slide and 
prepared for microscopic examination 
(Goldman et al., 2007). The rubber pipette 
was thoroughly rinsed between lavages to 
remove any residual cells before using it for 
the next animal.  
Staining of vaginal smears was adopted from 
the protocol described by Mclean et al. 
(2012). Exactly 0.1 g of crystal violet powder 
was added to 100 ml of double distilled water 
(ddH2O) and mixed thoroughly. Crystal violet 
stain (0.1%) was stored in a tightly sealed 
container at room temperature until needed. 
Using an eye dropper, crystal violet stain 
(0.1%), was dropped on one side of the cover 
slip. Excessive fluid was drained from the 
edges of the slide using a filter paper, until 
the stain was evenly distributed across the 
slide. The stained smear was observed under 
the light microscope (Ultra Medical MDI, 
Guangzhou Keyeah Optics & Electronics 
Instrument Co. LTD, China), immediately for 
the proportion of nucleated epithelial cells, 
cornified epithelial cells and leukocytes.  
Following the method described by Tropp and 
Markus, (2001), animals whose vaginal 
smears contained predominately leukocytes 
(60%) were classified as diestrus I or II. 
Smears that contained primarily nucleated 
epithelial cells (60%) and few leukocytes 
(10%) were classified as proestrus. Smears 
that contained primarily cornified cells (90%) 
were classified as estrus. Smears that 
contained primarily cornified cells (60%) with 
a significant number of leukocytes (20%) and 
nucleated epithelial cells (20%) were 
classified as metestrus. After cytological 
examination, stained smears were kept and 
photomicrographs were taken on a later date 
using Honestech TVR 2.5 software and in-
built camera of Ultra Medical MDI 
microscope, (Guangzhou Keyeah Optics & 
Electronics Instrument Co. LTD, China).  
Animals were sacrificed a day after the last 
administration of extract by cervical 
dislocation method. Through an 
abdominopelvic incision, both uterine horns 
and ovaries were removed, cleared of 
exogenous tissues and weighed.  
Briefly, the samples were fixed in Gender’s 
solution for 48 hours after which they were 
washed in distilled water and in 50% ethanol 
before re-fixing them in 10% neutral buffered 
formalin (Fischer et al., 2005). Samples of the 
left uterine horn and left ovary were grossed 
and processed through a 13 hour 25 minutes 
schedule in an automated tissue processor 
(SLEE MTP, Germany). Following processing, 
the tissues were embedded in paraffin wax 
and serially sectioned at 4µm using a 
microtome (SLEE, Germany) and stained with 
Haematoxylin and Eosin (H & E).  
Examination of the H&E slides was done under 
a light microscope (Nikon Ci-S, type 104c), 
with a Nikon digital sight DS Fi camera 
mounted and connected to a Toshiba 
computer screen. The structure of the 
endometrium, size of the lumen, and shape of 
endometrial glands and the proportion of the 
ovarian follicles, follicular stages and corpora 
lutea were studied.  Descriptive statistic was 
employed in evaluating the effects of C. 




gynandra on the estrous cycle. An image 
analysis software (ImageJ) was used for the 
quantitative analysis of the ovarian follicles. All 
numerical data were expressed as mean ± 
standard error of the mean (SEM), (n= 4 rats 
per group), using Microsoft excel 2010. 
Statistical significance (p), was calculated by 
one–way analysis of variance (ANOVA) using 
Graph pad prism, version 6. Any difference in 
means was further evaluated by Turkeys 
multiple comparison test of significance where 
p≤ 0.05 was considered to be significant. Data 
are presented using tables and bar charts. 
Results from histological analyses are 
presented as photomicrographs and 
interpreted appropriately. Data for the estrous 
cycle of the first and last ten days of 
administration was assessed and compared 
for estrous cycle disruption. 
 
RESULTS 
A comparison of the estrous cycle of the 
control and treated groups revealed a mild 
disruption of the estrous cycle in the last ten 
days of the administration (Fig. 1.1a and 
1.1b.) It was observed that animals in the 
highest treatment group (500mg/kg B.W), 
showed a persistent proestrous, followed by a 
reduction in estrous, metestrous and 
diestrous.   
Effects of C. gynandra on the estrous cycle of rats in the first ten days  
  
Figure 1.1a: Rats in different phases of estrous cycle during the first 10 days of the experiment. A significant 
difference was seen between control and the group given 250mg/kg B.W in the estrous stage (*p=0.05)   
*  
*  





 Figure 1.1b: Rats in different phases of estrous cycle during the last 10 days of the experiment. No significant  
change was seen between control and other treated groups (p>0.05).  
  
  
EFFECTS ON THE HISTOLOGY OF THE 
OVARY  
The ovarian interstitium from the rats in the 
treated groups was studded with vacuoles (Fig. 
2: plates 2 and 3) as compared to the control 
rats (Fig. 2, Plate 1). The vacuoles become 
more numerous with the 500mg/kg body 
weight daily dose (Fig. 2, plate 3). The 
developing ovarian follicles were more in the 
control rats than in the treated rats (Fig. 2).  
EFFECTS ON OVARIAN FOLLICLES  
The results of the ovarian follicular counting 
after treatment with C. gynandra are shown in 
table 1. In this experiment, the dose of 
500mg/kg B.W. daily, showed a significant 
(p<0.05) decrease in secondary follicle (1.25 ± 
0.25), when compared to that of control group 
(4.00 ±1.22). The dose of 250 mg/kg body 
weight showed a similar decrease in primordial 
follicle (2.5±1.19) and secondary follicle 
(3.25±0.47) but was not statistically 
significant. Similarly, a decrease in the number 
of primordial follicles was observed in the 
treated groups in relation to the control. An 
increase in number of atretic follicle  
(2.25± 1.60) was also recorded in dose of 
500mg/kg B. W. * compared to the control*  
(1.25±1.43), most of the atresia were seen in 
the graafian follicles.  
EFFECTS ON THE HISTOLOGY OF THE 
UTERUS  
The endometrium of the rats treated with 
500mg/kg B.W, lined by simple squamous 
epithelium was studded with numerous large 
vacuoles and very few endometrial glands (Fig. 
3C). The vacuoles were not as numerous in the 
250mg/kg B.W (Fig. 2B), instead, the 
endometrial glands with prominent 
cuboidal/columnar epithelium were abundant.   
 




                                                                                              
   
Figure 2: Transverse section through the ovary. A: Normal rat ovary, displaying oocytes at different stages of 
development. 1=primary follicle. 2=secondary follicle, AN= antral or tertiary follicle, CL=corpus luteum. In B, (250mg/kg 
BW) and C, (500mg/kg BW) note the vacuolation (V) of the interstitium, one graafian follicle (GF) and several corpora 
lutea (CL), (H &E Stain). Bar=100µm  
 
 




  Types of Follicles   
primordial  primary  secondary  graafian  atretic  
CONTROL  
1 ml dH2O  
3.75±0.47  2.25  
±0.47  
4.00±1.22*  2.75±0.47  1.25±1.43  
250mg/kg  
Low dose  
2.50±1.19  2.50±0.6 
4  
3.25±0.47  2.50±0.64  1.00±0.40  
500mg/kg  
High dose  
1.75±0.62  1.25±0.2 
5  
  
1.25±0.25*  1.50±0.64  2.25±1.60  
  
Significance was estimated by Turkey’S multiple comparison test (*p<0.05). Values are  
shown as mean ± SEM, (n=4).  









 Figure 3: Transverse section though the uterus. Plate 1: Normal uterus in control group, showing dilated lumen.  
Plate 2: Treated with 250mg/kg B.W of C. gynandra, displaying hyperplasia of luminal epithelium on one side (H), and 
low cuboidal/columnar glandular epithelium of endometrial glands. Plate 3: Treated with500mg/kg BW of C. gynandra. 
Several vacuoles (V) are seen in the endometrium with few endometrial glands (G), (H &E Stain). MY= myometrium; 
L= lumen; V=vacuoles, bar=100 µm  
   DISCUSSION  
A single cycle with a diestrous period of 4 days 
or longer and/or an estrous period of 3 days 
or longer was for the purposes of toxicological 
assessment, considered as unusual (Goldman 
et al., 2007). Following the estrous cycle data 
in this study, a comparison between the first 
and the last 10 days revealed an alteration in 
the duration of the phases of the estrous cycle 
in treatment groups when compared with that 
of the control. The cycle status in the 
treatment groups (250 and 500mg/kg/B.W 
daily) in the first 10 days of administration, 
was similar to the control. No striking changes 
were seen.  Results in the last 10 days in the 
250mg/kg B.W treated group is comparable to 
the untreated control rats with similar changes 
in proestrous, estrous, metestrous and 
diestrous phases of the cycle. However, in the 
500mg/kg B.W treated group, a remarkable 
increase in the proestrous phase, followed by 
a decrease in estrous, metestrous and 
disetrous phases was observed.   
Prolonged proestrous following administration 
of C. gynandra observed in the 500mg/kg B.W 
treated group, suggests a disturbance in 
ovulation, which is also a sign of fertility 
disorder probably caused by the presence of 
flavonoids, saponin and alkaloid components in 
C. gynandra leaf extract. Some of these 
phytochemicals have been implicated to cause 
disorder in estrous cycle in animals (Mustapha 
et al., 2011). Furthermore, data from the 
estrous cycle of this research agrees with 
Goldman et al. (2007), who stated that, 
substance treatment can bring about acyclicity 
branded by a persistent estrous, a persistent 
diestrus, or rather induce an irregular pattern 
with cycles of extended duration.  The 
persistence in the proestrus phase seen in this 
study, has also been reported elsewhere by 
Mustapha et al.  
(2011).   
The overall functioning of the reproductive 
system is largely influenced by 
physiologic/endocrine hormones (Paccola et 
al., 2013). The cyclic changes that occur in the 
ovaries and uterus are controlled by the 
hypothalamus through Gonadotropin-releasing 
hormone (GnRH) (Lee and Chow, 2008). This 
hormone circulates in the blood and causes the 
release of two hormones namely; follicle 
stimulating hormone (FSH) and luteinizing 
hormone (LH) from the pituitary gland (Xia et  




al., 2013). Follicle-stimulating hormone (FSH) 
is produced by the pituitary gland in the first 
half of the menstrual cycle. It is essential for 
follicular development in the ovaries.  
Toxicants that interfere with reproductive 
function can act directly on the organs of the 
reproductive system or indirectly through 
demonstrating its influence at the 
hypothalamic or/and pituitary gland level 
(Azarnia et al., 2008). During female 
reproductive life, most ovarian follicles 
undergo a degenerative process called atresia 
at some stage of their development, and only 
few follicles reach the ovulatory stage 
(Parimala and Kaliwal 2005). It has been 
shown that estrogens suppress follicular 
atresia and androgens enhances atresia (Billig 
et al., 1993). Under physiological conditions 
the majority of atresia occurs in secondary and 
tertiary follicles, while preovulatory follicles 
undergo a low rate of atresia (Gustavo et al., 
2015). This situation was present in the 
control group but slightly higher in the high 
dose group where the majority of atresia was 
observed in the graafian follicles.  
In vivo treatment of female rats with C. 
gynandra in this study resulted in a decrease 
in the number of primordial, secondary and 
graafian follicles in both treated groups when 
compared to control. A statistically significant 
decrease in secondary follicles was seen 
between 500mg/kg B.W treated group in 
relation to the control. Treatment of C. 
gynandra probably exerted an inhibitory effect 
on follicle development. This would explain the 
observed decease in follicular development and 
an increase in the atresia of follicles in the high 
dose group when compared to the control. 
These effects could be due to an underlying 
hormonal imbalance upon administration of C. 
gynandra which presents as decreased 
follicular development.  
Similarly, in a study by Deka and Kalita, (2016), 
the effect of C. gynandra methanolic leaf 
extracts was evaluated on folliculogenesis in 
sexually matured female albino mice with 
regular oestrus cycle. The experimental results 
showed a reducing effect on follicular 
development with the doses of C. gynandra 
leaf extract (methanolic) tested, following a 
treatment period of 21 days, with respect to 
control. Many other investigations have 
reported the disrupting effect of various plant 
extracts on ovarian folliculogenesis (Al-Qarawi 
et al., 2000; Solomon et al., 2010). These 
changes in the oocyte growth and maturation 
have been influenced by gonadotrophins and 
steroids along with growth factors which 
govern follicular development suggesting the 
possible reason of the inhibitory effect of these 
plant extracts on the folliculogenesis in rats.  
Histological analysis of the rat uteri was 
conducted in the control and treated groups. 
Uterine histology revealed that administration 
of C. gynandra at doses of 250mg/kg B.W and 
500mg/kg B.W, resulted in a disorganized 
cellular structure of the endometrium and 
disrupted endometrial gland structure. The 
epithelium of the endometrial glands 
lengthened in the 250mg/kg B.W group when 
compared to control uteri. The uteri of the 
control group appeared normal. Examination of 
the uteri of the higher treated group 
(500mg/kg B.W), in a larger magnification, 
clearly showed shortening of the epithelium of 
the endometrial glands, making the glands 
appear as cystic/vacuolated. The glands were 
replaced by several vacuoles. Specifically, 
vacuoles were obvious in the endometrial 
glands. Furthermore, cystic uterus and 
hyperplasia of cells in the uteri of treated rats 
were also observed.  Endometrial hyperplasia is 
a state of excessive proliferation of the cells of 
the endometrium, or inner lining of the uterus. 
Most cases of endometrial hyperplasia is a 
consequence of high levels of estrogens, 
combined with insufficient levels of the 
progesterone-like hormones which ordinarily 
counteract estrogens’ proliferative effects on 
this tissue (Horn et al., 2007). Endometrial 
hyperplasia is a major risk factor for the 
progress or even co-existence of endometrial 
cancer.   
In the present study, administration of a 
higher dose of C. gynandra could be 
causing a reduction in the epithelium of the 
endometrial glands. Loss of endometrial 
glands epithelium is related to infertility 
and presents defects of implantation. This 
suggests that, a uterus with a low glandular 
epithelium cannot accommodate a 
developing fetus to term. An association of 




endometrial glands and infertility has also 
been established elsewhere (Reardon et 
al., 2012). This, could be one of the 
mechanisms by which C. gynandra causes 
abortion.  
From previous studies, C. gynandra plant 
extracts have been shown to contain 
phytoestrogenic compounds (Deka and Kalita, 
2016). Phytoestrogenic plants, such as C. 
gynandra which contained saponins and 
flavonoids are capable of increasing the level of 
circulating estrogen in the female rats. The 
high level of estrogen prolongs estrous and 
proestrus phases of the estrous cycle, thereby 
interfering with fertility (Mustapha et al.,  
2011). It is believed that, these 
phytoestrogenic components of plants are 
known to reduce fertility in animals upon 
continuous administration. This could be the 
probable factors that caused disruption of 
estrous cycle phases that is observed in this 
study.   
In the last ten days of the experiment, it was 
evident that rats in the highest treatment 
group, rather progressing normally, stayed 
longer in the proestrous phase of the estous 
cycle. In the histology of the ovary, there was 
a reduction of ovarian follicles in the primordial 
and secondary follicle in the treated group. 
Atresia was also seen in the graaffian 
(matured) follicles. There was also a 
generalized vacuolization in both the ovarian 
and uterine histology. Less prominent 
endometrial glands were also seen in the 
uterine histology especially in the rats which 
received the highest dose.  
In conclusion, the results of this research show 
that the aqueous leaf extract of C. gynandra at 
a high dose, exerted negative influences on the 
estrous cycle and histomorphology of the ovary 
and uterus of female rats suggesting a 
disturbance on the reproductive health of the 
animals.   
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